In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Liothyronine Sodium Drug Master File in Korea (Liothyronine Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Liothyronine Sodium. The MFDS reviews the Liothyronine Sodium KDMF as part of the drug registration process and uses the information provided in the Liothyronine Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Liothyronine Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Liothyronine Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Liothyronine Sodium suppliers with KDMF on PharmaCompass.